Our study provides a 10-year picture of glucose lowering drugs (GLD) utilization.
We measured and compared temporal trends in GLD utilization between two countries.
A significant increase in Portuguese and Dutch GLD consumption was found (2004–2013).
In Portugal, there was a substitution of sulfonylureas for gliptins since 2007.
The lack of national guideline was the driver for behaviour prescribing differences.